This PhD project develops ultrasmall, intravenously deliverable hafnium oxide nanoparticles to improve radiotherapy for high-risk neuroblastoma, a pediatric cancer with poor prognosis and limited treatment options. Neuroblastoma remains a major unmet clinical need because high-risk disease is still associated with poor outcomes despite multimodal treatment, while conventional radio-chemotherapy is constrained by toxi…